NCT06966531Not yet recruiting
Prevalence of Myocarditis in Patients Suspected Myocardial Infarction With Non-Obstructive Coronary Arteries
Source: ClinicalTrials.gov · Last updated 12 May 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This study aims to determine the prevalence of myocarditis among patients suspected of having myocardial infarction with non-obstructive coronary arteries (MINOCA) and to analyze its clinical characteristics, diagnostic markers .
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 148 (estimated)
- First submitted
- 4 May 2025
- Start date
- 5 May 2025
- Primary completion date
- 1 Mar 2027
- Lead sponsor
- Assiut University
- Diseases
- Coronary artery disease
- NCT number
- NCT06966531
What you commit to
- Study type: Observational
- Planned participants: 148
- From 5 May 2025 to the primary completion date, 1 Mar 2027
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Prior history of myocarditis or cardiomyopathy.
Other illness
- Significant coronary artery disease (\>50% stenosis) on angiography.
Other
- Contraindications to CMR (e.g., pacemakers, severe renal dysfunction).
Who the study is looking for
- All patients; diagnosed with myocardial infarction with nonobstructive coronary arteries (MINOCA)
- clinical symptoms
- ECG : ischemic changes with or without ST segment elevation
- Echocardiograpy : segmental wall motion abnormalities (SWMA)
- positive cardiac enzymes
- Coronary angiography: insignificant lesions ,the absence of culprit obstructive coronary artery disease (epicardial coronary artery stenosis ≥50%)
Age in the registry: 17 years to 80 years · Sex: All
This page is information, not medical advice. Discuss any trial with your doctor.